Physician profile
Kirk Jeffers
NPI 1487041786
$33,233.32
in general payments reported to CMS, 2019-2025
14 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,490 · 2020: $24K · 2021: $3,007 · 2022: $1,516 · 2023: $233 · 2024: $415 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2020 | |
| Smith+Nephew, INC. | $5,184.93 | 2020-2022 | |
| Gemini Mountain Medical, LLC | $2,788.28 | 2020-2025 | |
| Alon Medical Technology | $2,464.00 | 2019 | |
| Stryker Corporation | $1,991.25 | 2019-2025 | Iconix, Knotilus Anchor, 3.5mm, Alphavent |
| Bioventus LLC | $350.08 | 2019-2025 | Exogen Ultrasound Bone Healing System, Gelsyn-3 |
| Zimmer Biomet Holdings, INC. | $189.94 | 2019-2025 | Rosa |
| Depuy Synthes Sales INC. | $71.76 | 2020-2025 | Healix Knotless Peek |
| Pacira Pharmaceuticals Incorporated | $48.08 | 2019-2025 | Exparel |
| Endo USA, INC. | $46.41 | 2025 | Xiaflex |
| Becton, Dickinson and Company | $35.29 | 2023 | |
| Acumed LLC | $25.17 | 2023 | Acumed |
| Vericel Corporation | $25.00 | 2025 | Maci |
| Agios Pharmaceuticals, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Jeffers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.